# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Fannie Lou Hamer (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML031-SYN
- Date: 2026-03-23
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lorraine Batiste-Hill, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week review of home blood pressure readings and the repeat urine test, with a kidney ultrasound and a nephrology telehealth consultation. **S**

## History of present illness

Mrs. Hamer returns two weeks after her first visit. She took her home blood pressure twice a day for seven days with the cuff the health center gave her, and the community health worker helped her write the readings down; they average 152/94. Her thirst and frequent urination are already less on metformin, with some loose stools in the first week that have settled. She had her kidney ultrasound this morning at the health center, after the sonographer explained each step; she asked for her companion to stay in the room, and she did. She then spoke with Dr. Agbaje of nephrology by video from the clinic, with the community health worker beside her. Her SNAP and energy assistance applications have been sent. She asked why she needs two new medicines and what they will cost. **S**

| Element | Detail |
|---|---|
| Home blood pressure | Average 152/94 over seven days |
| Metformin | Loose stools the first week, now settled; thirst less |
| Kidney ultrasound | This morning, with her consent and a companion present |
| Benefits | SNAP and energy assistance applications sent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; less thirst |
| Cardiovascular | Negative | No chest pain or ankle swelling |
| Gastrointestinal | Negative | Loose stools settled |
| Genitourinary | Negative | Urinating less often; no burning |
| Musculoskeletal | Positive | Leg and back aching after long days |

5 systems reviewed. **S**

## Current medications

- Metformin extended-release 500 mg oral tablet, one tablet with the evening meal for one week, then two tablets with the evening meal **S**
- Atorvastatin 40 mg oral tablet, one tablet daily **S**
- Amlodipine 5 mg and benazepril 20 mg combined oral capsule, one capsule daily **S**
- Dapagliflozin 10 mg oral tablet, one tablet daily; stop on days of vomiting, diarrhea or not eating, and before surgery **S**

## Allergies

- No known allergy **S**

## Objective

BP 156/96 mmHg; pulse 82 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 92.6 kg; BMI 34.9 kg/m². All vital signs are synthetic.

Urine albumin-to-creatinine ratio: 96 mg/g (high). All results are synthetic.

## Change since baseline

- Urine albumin-to-creatinine ratio: 88 mg/g (high) at baseline, 96 mg/g (high) at this visit **S**

## Immunizations given today

- Pneumococcal conjugate vaccine PCV20 **S**
- Hepatitis B vaccine (HepB-CpG), dose 1 of 2 **S**
- Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) **S**

## Physical examination

| System | Finding |
|---|---|
| Consent and chaperone | Blood pressure, heart, lung and ankle examination explained and agreed; female nurse present |
| General | Well; blood pressure 156/96 (average of two readings), pulse 82 |
| Cardiovascular | Regular rhythm; no murmur; no ankle swelling |
| Respiratory | Clear |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hypertension with chronic kidney disease** (I12.9). Home readings average 152/94 with clinic 156/96: stage 2 hypertension confirmed. ECG at intake showed sinus rhythm without left ventricular hypertrophy; TSH normal. With albumin in the urine, an ACE inhibitor is needed, and at this level two medicines are recommended from the start. **S**
   - Amlodipine 5 mg with benazepril 20 mg in one daily capsule, on the low-cost generic list.
   - Home readings twice a week.
   - Potassium and creatinine in one to two weeks at the health center.
   - Goal below 130/80.
2. **Chronic kidney disease G2 A2** (N18.2). Repeat urine albumin-to-creatinine ratio 96 mg/g, confirming moderately increased albuminuria; eGFR 73. Ultrasound: right kidney 9.0 cm with a lower-pole cortical scar, left kidney 11.4 cm and normal, no blockage or stones. Dr. Agbaje judges the scarring consistent with her old injury, with diabetes and blood pressure adding to the albumin loss. **S**
   - Dapagliflozin 10 mg daily for kidney protection, at the discount pharmacy price; stop it on days she cannot eat or drink.
   - No ibuprofen or naproxen; acetaminophen for aching.
   - Urine albumin again in three to four months.
3. **Type 2 diabetes** (E11.65). Tolerating metformin extended-release 1,000 mg; symptoms easing. Dapagliflozin will also lower glucose without causing low blood sugar. **S**
   - Continue metformin.
   - Diabetes education class at the health center next month, with a ride arranged.
4. **Food insecurity** (Z59.41). SNAP application sent with the community health worker's help; health center food pantry and produce program started. **S**
   - Community health worker to follow the application.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Consent and chaperone for every examination, test and procedure | Every visit | Completed today | Ultrasound, blood pressure, examination, vaccines and blood tests each explained and agreed; companion present for the ultrasound at her request |
| Examination | Clinic blood pressure (seated, two readings, large cuff) | Every visit | Completed today | 156/96 |
| Self-management | Home blood pressure readings | Seven days to confirm the diagnosis; then twice a week, and daily for a week after any change | Completed today | Seven-day average 152/94 confirms hypertension |
| Examination | Weight and BMI | Every visit | Completed today | 92.6 kg, BMI 34.9 |
| Laboratory | Potassium, creatinine and eGFR | One to two weeks after starting an ACE inhibitor, then every 6 months (more often with changes) | Ordered | Benazepril started today; check booked in one to two weeks |
| Laboratory | Urine albumin-to-creatinine ratio | Repeat to confirm; 3 to 6 months after a treatment change; then every 6 months while moderately increased | Completed today | 96 mg/g, confirming the intake result of 88 |
| Imaging | Kidney ultrasound | Once, for reduced kidney function with an old injury | Completed today | Small scarred right kidney; normal left kidney; no blockage |
| Laboratory | Hemoglobin A1c | Every 3 months until at goal, then every 6 months | Up to date | 8.6% at intake; next in three months |
| Laboratory | Lipid panel | 4 to 12 weeks after starting a statin, then yearly | Up to date | LDL 146 at intake; atorvastatin started at intake; recheck at four to twelve weeks |
| Examination | Baseline ECG and TSH | At the diagnosis of hypertension | Up to date | Done at intake: sinus rhythm without left ventricular hypertrophy; TSH 2.1 |
| Medication safety | Medicine safety: low blood sugar, sick-day rules, genital infections, cough, swelling, adherence and cost | Every visit | Completed today | Loose stools on metformin settled; sick-day rules for dapagliflozin and benazepril explained and written down; cost checked with the pharmacist |
| Medication safety | Pneumococcal, hepatitis B and Tdap vaccines | Once (hepatitis B as two doses a month apart) | Completed today | PCV20, hepatitis B dose 1 and Tdap given after she agreed |
| Survey | Social needs screen (AHC-HRSN) and resources | At intake, then every few months while needs are open | Completed today | Food, transportation and utility needs from intake; SNAP and energy assistance applications sent; pantry and produce program started |
| Referral | Nephrology review | At diagnosis; then by telehealth if albumin stays raised | Completed today | Seen by Dr. Agbaje by telehealth today |

## Goal progress

- Every examination, test and procedure explained first and done only with her documented agreement, with a chaperone of her choosing, at every visit. In progress; target 2026-10-19. **S**
- Blood pressure below 130/80 mmHg in the clinic and at home within six months. In progress; target 2026-10-19. **S**
- A1c below 7% within six to nine months, without low blood sugar. In progress; target 2026-10-19. **S**
- Urine albumin-to-creatinine ratio lower by at least 30% within six months. In progress; target 2026-10-19. **S**
- Food and utility needs met through benefits, and a dependable way to reach every visit and laboratory test. In progress; target 2026-10-19. **S**
- LDL cholesterol below 70 mg/dL. In progress; target 2026-10-19. **S**

## Medication changes

- Started: Amlodipine 5 mg and benazepril 20 mg combined oral capsule, one capsule daily **S**
- Started: Dapagliflozin 10 mg oral tablet, one tablet daily; stop on days of vomiting, diarrhea or not eating, and before surgery **S**

## Guideline basis

- Introduction and Methodology: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2026 (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1))
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (J Am Coll Cardiol 2025)
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024), Kidney Disease: Improving Global Outcomes (Kidney International)
- CMID: Clinical Monitoring Intelligence Database, hypertension, diabetes type 2, hyperlipidemia, chronic kidney disease and depression monographs (2026), Aether Forge
- Trauma-Informed Care in Behavioral Health Services (Treatment Improvement Protocol 57) (2014), Substance Abuse and Mental Health Services Administration
- Code of Medical Ethics Opinion 2.1.1: Informed Consent (2026), American Medical Association
- The Accountable Health Communities Health-Related Social Needs Screening Tool (2017), Centers for Medicare & Medicaid Services
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Potassium and creatinine in one to two weeks at the health center, with a ride. Review in six weeks with lipids, retinal photographs and the second hepatitis B dose. Call for dizziness, ankle swelling, a cough that will not stop, swelling of the lips or tongue (call 911), or vomiting that stops her drinking. **S**
- Next scheduled visit 2026-05-04: six-week review: blood pressure, kidney function and potassium after the new medicines, lipids, retinal photographs, and benefits. **S**
